v3.22.0.1
STOCK TRANSACTIONS, OPTIONS AND WARRANTS
6 Months Ended
Dec. 31, 2021
Disclosure Text Block Supplement [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]

NOTE 6 STOCK OPTIONS AND WARRANTS

 

On July 22, 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”) which contains provisions for up to 5,000,000 stock-based instruments to be granted to employees, consultants and directors.

 

On October 26, 2021, the Board of Directors adopted the 2022 Equity Incentive Plan (the “2022 Plan”) which contains provisions for up to 10,000,000 stock-based instruments to be granted to employees, consultants and directors.

 

Effective September 24, 2020, the Company filed a Certificate of Withdrawal of the Certificate of Designation related to the Company’s 2013 Series Convertible Preferred Stock. In doing so, the 2,000,000 shares of preferred stock previously designated as 2013 Series Convertible Preferred Stock returned to the status of authorized and unissued shares of “blank check” preferred stock, and as a result we now have a total of 5,000,000 shares of preferred stock under our Articles of Incorporation which may be designated in one or more series with such relative rights, preferences and limitations as the Board of Directors may determine. The Company may file one or more new designations authorizing the issuance of preferred shares should this be needed in the future as may be determined by the Board of Directors.

 

All previously granted stock options expired as of December 31, 2021; no stock options have been granted as of December 31, 2021 or thus far in fiscal year 2022.

 

A summary of the status of our outstanding stock options as of December 31, 2021 and June 30, 2021 and changes during the periods then ended is presented below:

 

   

December 31, 2021

   

June 30, 2021

 
           

Weight Average

   

Intrinsic

           

Weight Average

   

Intrinsic

 
   

Shares

   

Exercise Price

   

Value

   

Shares

   

Exercise Price

   

Value

 

Outstanding beginning of period

    1,030,000     $ 0.12               2,870,000     $ 0.12          

Granted

    -     $ 0.00               -     $ 0.00          

Expired/Cancelled

    (1,030,000

)

  $ (0.12

)

            (1,840,000

)

  $ (0.12 )        

Exercised

    -     $ 0.00               -     $ 0.00          

Outstanding end of period

    -     $ 0. 00     $ -       1,030,000     $ 0.12     $ -  

Exercisable

    -     $ 0. 00     $ -       1,030,000     $ 0.12     $ -